Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura

Academic Article

Abstract

  • © 2016 Wiley Periodicals, Inc. Thrombotic thrombocytopenic purpura (TTP) has >90% mortality without therapeutic plasma exchange (TPE). Despite TPE, approximately 10% of patients still die, presumably from cardiac ischemia. We sought clinical or laboratory parameters associated with death by reviewing the records of all patients hospitalized with acquired TTP in our institution for 10 years, and collect demographics and results for hemoglobin, platelet count, creatinine, lactate dehydrogenase, transaminases, total bilirubin, creatinine kinase (CK), CK-MB, and troponin I. Sixty-eight patients were admitted 88 times, and 11 died. Survivors and non-survivors were similar in terms of sex, ethnicity, thrombocytopenia, and degree of anemia at presentation, while the latter were older, had worse renal function and higher CK, CK-MB, and troponin I (univariate analysis). However, only troponin I remained significant on multivariate analyses. We propose that patients with TTP should be monitored with troponin I to detect significant myocardial ischemia that could predict death despite TPE.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Brazelton J; Oster RA; McCleskey B; Fuller J; Adamski J; Marques MB
  • Start Page

  • 311
  • End Page

  • 318
  • Volume

  • 32
  • Issue

  • 5